NGL Fine Chem
1,303.20
-12.30(-0.94%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-0.94%
1M-20.05%
6M+21.44%
1Y-29.27%
5Y-30.27%
View Company Insightsright
Latest news about NGL Fine Chem
NGL Fine-Chem Invests Rs. 119.83 Crore in Plant Expansion During Q1 Aug 07, 2025
NGL Fine-Chem Reports Robust Q1FY26 Performance Amid Industry Headwinds Aug 07, 2025
NGL Fine-Chem Reports Strong Q1 FY2026 Results with 18.6% Revenue Growth Aug 01, 2025
NGL Fine-Chem Reports Sharp Decline in Q4 Profits, Announces Dividend May 22, 2025
More news about NGL Fine Chem
26Mar 25
NGL Fine Chem Achieves Milestone with Partial Expansion at Plant S-18
NGL Fine Chem Limited has partially completed the expansion of Plant S-18 and commenced pilot batch production on March 11, 2025. The company has obtained necessary approvals from the Maharashtra Pollution Control Board (MPCB) for the expanded facility. This milestone marks a significant step in the company's growth strategy, potentially enhancing its production capabilities in the fine chemicals sector. The expansion is expected to increase production capacity and improve operational efficiency.
26Feb 25
NGL Fine-Chem Settles Disclosure Violation Case with SEBI for ₹92.21 Lakh
NGL Fine-Chem Limited and its promoters have settled with SEBI for ₹92.21 lakh regarding shareholding disclosure violations from 2002 to 2019. The company incorrectly classified PCI Ferrmone Chemicals as 'public/non-promoter' instead of 'promoter group' for 31 quarters. Promoters failed to disclose PCI Ferrmone's shareholding in their SAST disclosures. The settlement, reached without admission of guilt, includes payments from the company (₹54.42 lakh), PCI Ferrmone, and two promoters (₹12.60 lakh each). NGL Fine-Chem states the settlement won't impact its financial or operational activities beyond the payment.
NGL Fine Chem
1,303.20
-12.30
(-0.94%)
1 Year Returns:-29.27%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)